A Study to Evaluate ENERGI-F703 GEL in Venous Leg Ulcer

Summary

This is a randomized, double-blind, placebo-controlled, phase II, multi-centered study to evaluate the efficacy and safety of ENERGI-F703 GEL in subjects who are ≥ 20 years old with venous leg ulcer (VLU). Subjects will be recruited from multiple sites in Taiwan. The treatment period will be 84 days with another 84-day follow-up period.

Timeline

Start

2022-07-26

Primary completion

2025-03-15

Completion

2025-06-15

Drugs

Indications